Jia, Y., Ali, S. M., Saad, S., Chan, C. A., Miller, V. A., & Halmos, B. (2014). Successful treatment of a patient with Li–Fraumeni syndrome and metastatic lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with the pan-HER inhibitor afatinib. Landes Bioscience.

Jia, Yuxia, Siraj M. Ali, Shumaila Saad, Courtney A. Chan, Vincent A. Miller, and Balazs Halmos. Successful Treatment of a Patient With Li–Fraumeni Syndrome and Metastatic Lung Adenocarcinoma Harboring Synchronous EGFR L858R and ERBB2 Extracellular Domain S310F Mutations With the Pan-HER Inhibitor Afatinib. Landes Bioscience, 2014.

Jia, Yuxia, et al. Successful Treatment of a Patient With Li–Fraumeni Syndrome and Metastatic Lung Adenocarcinoma Harboring Synchronous EGFR L858R and ERBB2 Extracellular Domain S310F Mutations With the Pan-HER Inhibitor Afatinib. Landes Bioscience, 2014.